Your browser doesn't support javascript.
Has COVID-19 Affected Cancer Screening Programs? A Systematic Review.
Alkatout, Ibrahim; Biebl, Matthias; Momenimovahed, Zohre; Giovannucci, Edward; Hadavandsiri, Fatemeh; Salehiniya, Hamid; Allahqoli, Leila.
  • Alkatout I; Kiel School of Gynaecological Endoscopy, University Hospitals Schleswig-Holstein, Kiel, Germany.
  • Biebl M; Department of Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Momenimovahed Z; Department of Midwifery and Reproductive Health, Faculty of Nursing and Midwifery, Qom University of Medical Sciences, Qom, Iran.
  • Giovannucci E; Departments of Nutrition and Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, United States.
  • Hadavandsiri F; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
  • Salehiniya H; Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Allahqoli L; Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Front Oncol ; 11: 675038, 2021.
Article in English | MEDLINE | ID: covidwho-1256394
ABSTRACT

BACKGROUND:

Health care services across the world have been enormously affected by the onset of the coronavirus disease 2019 (COVID-19). Services in oncology have been curtailed because medical services have been focused on preventing the spread of the virus and maximizing the number of available hospital beds. The present study was designed to investigate the impact of COVID-19 on cancer screening.

METHODS:

Databases such as Medline, Web of Science Core Collection (Indexes = SCI-EXPANDED, SSCI, A & HCI Timespan) and Scopus were searched comprehensively for articles published until January 2021. The keywords used were COVID-19 and cancer screening, Articles dealing with cancer screening in the COVID-19 pandemic were included in the review.

RESULTS:

The review comprised 17 publications. The impact of COVID-19 was categorized into four dimensions a significant decline in cancer screening and pathology samples, the cancer diagnosis rate, an increase in advanced cancers, mortality rate and years of life lost (YLLs).

CONCLUSION:

Cancer screening programs have been clearly interrupted since the onset of the COVID-19 disease. The anticipated outcomes include delayed diagnosis and marked increases in the numbers of avoidable cancer deaths. Urgent policy interventions are needed to handle the backlog of routine diagnostic services and minimize the harmful effects of the COVID-19 pandemic on cancer patients.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Reviews / Systematic review/Meta Analysis Language: English Journal: Front Oncol Year: 2021 Document Type: Article Affiliation country: Fonc.2021.675038

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Reviews / Systematic review/Meta Analysis Language: English Journal: Front Oncol Year: 2021 Document Type: Article Affiliation country: Fonc.2021.675038